To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Society of Nuclear Medicine & Molecular Imaging
The Society of Nuclear Medicine & Molecular Imaging featured research recently published by Karmanos scientists. Nerissa Viola, Ph.D., leader of the Molecular Imaging Research Program at Karmanos and associate professor at Wayne State University School of Medicine, and several Karmanos researchers and physicians published “Detection of IL12/23p40 via PET visualizes inflammatory bowels disease" in the Journal of Nuclear Medicine in July 2023. The team discovered that inflammatory bowel disease (IBD) can be imaged by using positron emission tomography (PET) imaging. IBD includes Crohn’s disease and ulcerative colitis. Both conditions increase a patient’s risk of developing colorectal cancer.
Read the article here.